World Pharma Newsfeed
Scientists find 95 genetic variants associated with heart disease risk factor
An international team of scientists has identified 95 genetic variants associated with high blood cholesterol and trigly...
Image of new antibiotic in action opens up new opportunities
Detailed pictures showing how a new type of experimental antibiotic can kill bacteria already resistant to existing trea...
Clinical Trials 2010 - Frankfurt
29 - 30 September 2010, Frankfurt, Germany.
In the current environment where minimising cost and delivering ROI are crit...
TEMPO study further demonstrates the benefits of Azilect® in early Parkinson's disease patients
H. Lundbeck A/S (Lundbeck) and Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) have announced newly published long-te...
Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen
Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced results of two phase 3 studies of mi...
Shire Proposes to Expand Specialist Gastrointestinal Portfolio
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that a Luxembourg incorpo...
Scientists launch new attack against AIDS
EU-funded researchers have developed a new defence against infection from the AIDS (acquired immune deficiency syndrome)...
AstraZeneca Second Quarter and Half Year Results 2010
Revenue in the second quarter increased by 1 percent at CER, but was up 3 percent on an actual basis as a result of the ...
Bayer increases sales and earnings in the second quarter
Sales of the Bayer Group rose by 14.6 percent in the second quarter, to EUR 9,179 million (Q2 2009: EUR 8,009 million). ...
FDA Grants Priority Review to Cladribine Tablets
Merck KGaA announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (...
